Sort   by:  
 Page size 
UnknownGait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment.
Not available
S-EPMC7946649 | biostudies-literature
UnknownTargeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Not available
S-EPMC9992000 | biostudies-literature
UnknownAssociation of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.
Not available
S-EPMC3072270 | biostudies-literature
UnknownClinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
Not available
S-EPMC5067228 | biostudies-literature
UnknownExploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel.
Not available
S-EPMC11438373 | biostudies-literature
UnknownResident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents.
Not available
S-EPMC8417651 | biostudies-literature
UnknownZRSR2 loss causes aberrant splicing in JAK2<sup>V617F</sup>-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.
Not available
S-EPMC12439484 | biostudies-literature
UnknownThe impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Not available
S-EPMC12583187 | biostudies-literature
UnknownA pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Not available
S-EPMC9701192 | biostudies-literature
UnknownPrediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.
Not available
S-EPMC9092400 | biostudies-literature
Sort   by:  
 Page size